These S&P500 stocks are gapping in today's session
By Mill Chart
Last update: Dec 2, 2022
Let's have a look at the S&P500 gap up and gap down stocks in today's session.
Gap down stocks
| Ticker | Change | Comment |
|---|---|---|
| EQT | -4.0% | EQT CORP's (NYSE:EQT) stock price decreased by 4.0% to $39.86 with a gap of 8.14%. In the last year the share price increased with 112.0%. |
| CCL | -3.61% | CARNIVAL CORP's (NYSE:CCL) stock price decreased by 3.61% to $9.61 with a gap of 8.16%. Shareholders saw the stock price going 26.2% lower is the past 6 months. |
| SNPS | -3.54% | SYNOPSYS INC's (NASDAQ:SNPS) stock price is declining with 3.54% to a price of $345.18 with a gap of 6.45%. Shareholders saw the stock price going 27.3% higher in the past month. |
| PYPL | -3.46% | PAYPAL HOLDINGS INC's (NASDAQ:PYPL) stock price is declining with 3.46% to a price of $75.81 with a gap of 6.68%. Shareholders saw the stock price going 57.3% lower is the past year. |
| APTV | -3.46% | APTIV PLC's (NYSE:APTV) stock price is declining with 3.46% to a price of $101.55 with a gap of 6.12%. Shareholders saw the stock price going 35.21% lower is the past year. |
| FTNT | -3.45% | FORTINET INC's (NASDAQ:FTNT) stock price is declining with 3.45% to a price of $53.47 with a gap of 4.66%. |
| ILMN | -3.35% | ILLUMINA INC's (NASDAQ:ILMN) shares fell 3.35% to $213.47 during Friday's session with a gap of 5.84%. Shareholders saw the stock price going 36.4% lower is the past year. |
| ANET | -3.31% | ARISTA NETWORKS INC's (NYSE:ANET) stock price is declining with 3.31% to a price of $135.15 with a gap of 5.39%. In the last 6 months the stock gained 35.49%. |
| WFC | -3.19% | WELLS FARGO & CO's (NYSE:WFC) shares fell 3.19% to $45.38 with a gap of 6.43%. Yesterday the company had a press release: Wells Fargo Named a Global Best in Service Winner by Euromoney Magazine. |
| ADI | -3.15% | ANALOG DEVICES INC's (NASDAQ:ADI) stock price decreased by 3.15% to $166.07 with a gap of 4.6%. The stock is trading 21.41% higher than a month ago. |
For the full top loser list go to our gap down stocks screener.
ILLUMINA INC
NASDAQ:ILMN (4/24/2024, 7:09:32 PM)
After market: 125.95 +3.08 (+2.51%)122.87
-1.59 (-1.28%)
ILMN News
Illumina chairman and Hologic CEO Stephen MacMillan is no stranger to dealing with well-known activist investors.
6 days ago - Zacks Investment ResearchCan Illumina (ILMN) Keep the Earnings Surprise Streak Alive?Illumina (ILMN) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
9 days ago - InvestorPlaceThe Cathie Wood Stock Shuffle: 4 Names She’s Loving, 3 She’s LeavingInvesting with the Ark Invest guru is a roller coaster ride, but she always keeps her big ideas for the future in front of her.
9 days ago - Market News VideoNotable Tuesday Option Activity: META, ILMN, COST9 days ago - Market News VideoIllumina Becomes Oversold (ILMN)9 days ago - Market News VideoNasdaq 100 Movers: TSLA, AMD
10 days ago - ChartmillTop S&P500 movers in Monday's sessionCurious about the S&P500 stocks that are in motion on Monday? Join us as we explore the top movers within the S&P500 index during today's session.
10 days ago - ChartmillWhat's going on in today's session: S&P500 moversWondering what's happening in today's session for the S&P500 index? Stay informed with the top movers within the S&P500 index on Monday.
10 days ago - ChartmillWondering what's happening in today's session regarding gap up and gap down stocks? Explore the S&P500 index on Monday to uncover the stocks that are gapping in the S&P500 index.Gapping S&P500 stocks in Monday's session
13 days ago - Illumina, Inc.Illumina's planned divestment of GRAIL approved by the European Commission/PRNewswire/ -- Illumina, Inc. (NASDAQ: ILMN), a global leader in DNA sequencing and array-based technologies, today announced it has received approval of its...
13 days ago - Yahoo FinanceUPDATE 1-EU approves Illumina's plan to divest cancer test maker GrailU.S. gene sequencing company Illumina's plan to divest cancer diagnostic test maker Grail has received the green light from EU antitrust regulators which blocked the deal two years ago. Illumina jumped the gun in 2021 when it completed the $7.1-billion acquisition before first securing EU regulatory approval. That prompted the European Commission, which acts as the competition enforcer in the 27-country European Union, to order the company to keep Grail separate from Illumina.
15 days ago - Yahoo FinanceUPDATE 2-Illumina CFO Goswami to depart, former Summit Therapeutics exec Dhingra to succeedIllumina said on Tuesday Chief Financial Officer Joydeep Goswami will leave the gene sequencing company and be succeeded by former Summit Therapeutics' executive Ankur Dhingra. Goswami, who has more than two decades of experience in the life sciences industry, was the CFO since early 2023 and will serve as an adviser till June 30, the company said. Prior to Summit, Dhingra was the CFO at medical test maker CareDx.
